Relationship between locomotive syndrome and frailty in rheumatoid arthritis patients by locomotive syndrome stage.

25-question Geriatric Locomotive Function Scale Frailty Kihon Checklist locomotive syndrome rheumatoid arthritis

Journal

Modern rheumatology
ISSN: 1439-7609
Titre abrégé: Mod Rheumatol
Pays: England
ID NLM: 100959226

Informations de publication

Date de publication:
18 Apr 2022
Historique:
received: 09 04 2021
revised: 13 05 2021
accepted: 09 06 2021
pubmed: 14 12 2021
medline: 20 4 2022
entrez: 13 12 2021
Statut: ppublish

Résumé

This study aimed to evaluate the association between locomotive syndrome (LS) and frailty in rheumatoid arthritis (RA) patients. Subjects were 538 RA patients (female, 72.9%; mean age ± standard deviation, 66.8 ± 13.4 years). LS and frailty were defined as ≥16 points on the 25-question Geriatric Locomotive Function Scale (Stage ≥2) and ≥8 points on the Kihon Checklist (KCL), respectively. There were 214 subjects with Stage ≥2 LS (39.8%) and 213 subjects with frailty (39.6%). Among subjects with Stage 0, 1, 2, and 3 LS, 11.0%, 21.9%, 48.3%, and 84.6% had frailty, respectively. The KCL points for cognitive and psychosocial factors had no significant differences across LS stages. Multivariable logistic regression analysis revealed that the Health Assessment Questionnaire was independently associated with frailty and LS stage, and the Clinical Disease Activity Index was associated with LS stage but not frailty. As LS worsens in RA patients, the likelihood of developing physical frailty increases. RA patients with a low LS stage can still develop frailty, and suppressing disease activity may not be sufficient to prevent frailty. These findings highlight the need to screen for frailty in RA patients and consider appropriate interventions based on each patient's condition, focusing on nonphysical factors.

Identifiants

pubmed: 34897498
pii: 6363895
doi: 10.1093/mr/roab024
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

546-553

Informations de copyright

© Japan College of Rheumatology 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Yasumori Sobue (Y)

Department of Orthopedic Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.

Mochihito Suzuki (M)

Department of Orthopedic Surgery, Nagoya University School of Medicine, Nagoya, Japan.
Department of Orthopedic Surgery, Japan Community Health care Organization Kani Tono Hospital, Kani, Japan.

Yoshifumi Ohashi (Y)

Department of Orthopedic Surgery, Nagoya University School of Medicine, Nagoya, Japan.
Department of Orthopedic Surgery, Yokkaichi Municipal Hospital, Yokkaichi, Japan.

Hiroshi Koshima (H)

Department of Orthopedic Surgery, Japan Community Health care Organization Kani Tono Hospital, Kani, Japan.

Nobuyuki Okui (N)

Department of Orthopedic Surgery, Yokkaichi Municipal Hospital, Yokkaichi, Japan.

Koji Funahashi (K)

Department of Orthopedic Surgery, Kariya Toyota General Hospital, Kariya, Japan.

Hisato Ishikawa (H)

Department of Orthopedic Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.

Shuji Asai (S)

Department of Orthopedic Surgery, Nagoya University School of Medicine, Nagoya, Japan.

Kenya Terabe (K)

Department of Orthopedic Surgery, Nagoya University School of Medicine, Nagoya, Japan.

Yutaka Yokota (Y)

Department of Orthopedic Surgery, Nagoya University School of Medicine, Nagoya, Japan.

Kenji Kishimoto (K)

Department of Orthopedic Surgery, Nagoya University School of Medicine, Nagoya, Japan.

Nobunori Takahashi (N)

Department of Orthopedic Surgery, Nagoya University School of Medicine, Nagoya, Japan.

Shiro Imagama (S)

Department of Orthopedic Surgery, Nagoya University School of Medicine, Nagoya, Japan.

Toshihisa Kojima (T)

Department of Orthopedic Surgery, Nagoya University School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH